Transitioning from SBIR Phase I to Phase II in 2026

Crossing from SBIR Phase I into Phase II is one of the most consequential transitions a small business can make in the federal funding landscape. The two phases are not simply sequential checkboxes — they represent a fundamental shift in what agencies expect from you, how you prove your value, and how you position your technology for the long road ahead.

The national average Phase I to Phase II conversion rate hovers around 40 to 45 percent, meaning more than half of Phase I awardees never make the leap. Understanding why — and how to be on the right side of that statistic — is exactly what this guide is about.

Understanding What Phase II Actually Evaluates

A common misconception is that Phase II is simply a larger Phase I. It is not. Phase I exists to establish technical feasibility. Phase II exists to demonstrate that your technology can be developed into a viable product or service with real commercial potential.

Program officers at agencies like NSF, NIH, DoD, and DOE are not just asking whether your research worked. They are asking whether you have a credible path to market, a team capable of executing at scale, and a business model that justifies continued public investment. Your Phase II application needs to answer all three of those questions clearly and convincingly.

The technical narrative still matters, of course. But in 2026, agencies are placing increasing weight on commercialization strategy as part of their evaluation criteria. NSF in particular has made commercialization planning a centerpiece of its SBIR Phase II review process through the America's Seed Fund program.

Building Your Case During Phase I

The strongest Phase II applications are not written after Phase I ends. They are assembled throughout the entire Phase I performance period. If you are currently in a Phase I award, the decisions you make today will shape the strength of your Phase II proposal.

Here is what to focus on:

• Document your technical milestones thoroughly, even when results are mixed. Reviewers respect honest reporting far more than inflated claims.
• Begin customer discovery early. NSF's I-Corps program, which integrates with the SBIR pathway, is specifically designed to help Phase I awardees validate commercial assumptions before they write Phase II proposals.
• Establish at least one or two letters of support from potential customers, partners, or licensees. These do not need to be contracts — meaningful expressions of genuine interest from credible organizations carry significant weight.
• Track your IP position. If a patent application is in progress, note its status. Agencies want to see that you are protecting the technology they have helped fund.
• Build your team deliberately. Phase II budgets often exceed $750,000 and can reach $2 million at some agencies. Reviewers will scrutinize whether your current team can realistically execute at that scale.

Writing a Phase II Proposal That Converts

The mechanics of a strong Phase II proposal are distinct from Phase I in several important ways.

First, your research objectives need to be more specific and milestone-driven. Vague technical goals that might have passed muster in a feasibility study will not hold up under Phase II scrutiny. Think in terms of clearly defined deliverables tied to defined timeframes.

Second, your commercialization plan needs to be substantive rather than aspirational. Describe your target market with actual data. Name the competitive landscape. Explain your go-to-market strategy in enough detail that a reviewer who has never heard of your technology can understand how it will reach end users. Agencies like DoD also want to understand the transition path — specifically, which program office or prime contractor might ultimately adopt your solution.

Third, budget justification deserves more attention than most applicants give it. Every line item should be defensible. Unexplained or poorly scoped budget requests are a red flag for reviewers and can delay or derail an otherwise strong application.

The Role of Subcontractors and Collaborators

Many successful Phase II awardees bring in subcontractors or university collaborators to fill capability gaps or add credibility to their technical approach. If you plan to include subcontractors, get their statements of work and budget justifications prepared well in advance. Late-stage scrambling to finalize partnerships shows in the quality of the proposal.

University partnerships can also signal to reviewers that your technical approach has independent validation. However, keep the primary work within your company. SBIR rules require that the small business perform a majority of the research, and proposals that appear to outsource the core technical work raise compliance concerns.

Timing, Deadlines, and Agency Nuances

Each federal agency that runs an SBIR program has its own timeline and solicitation schedule. In 2026, most agencies continue to operate on rolling or semi-annual solicitation cycles, though this varies. NIH, for instance, uses standard application due dates throughout the year, while DoD releases topic-driven solicitations on a structured cycle.

One practical consideration: many agencies allow or require Phase II applications to be submitted within a specific window after Phase I completion. Missing that window can mean waiting an entire cycle or, in some cases, losing eligibility entirely. Know your agency's specific rules and build backward from the deadline.

Also be aware that some agencies offer Phase I Option awards or Phase I/II Fast-Track mechanisms that can compress the timeline between phases. If your technology is on a competitive development timeline, these pathways are worth exploring.

Leveraging Phase II Enhancement Programs

Several agencies offer supplemental funding mechanisms that can strengthen your Phase II position. NIH's Phase IIB Competing Renewal, USDA's Phase II matching fund, and various DoD Commercialization Readiness Programs are examples of opportunities that can extend or expand your Phase II funding when paired with private investment or commercial contracts.

These programs typically require you to bring matching funds or demonstrated commercial traction to the table. Planning for them early — rather than discovering them after your Phase II ends — can substantially extend your runway.

After the Award: Setting Up Phase III

Phase III is where SBIR funding technically ends and the commercial world begins. No direct SBIR funds flow in Phase III, but the pathway matters enormously. Some agencies, particularly within DoD, are increasingly focused on how Phase II awardees transition into production contracts or integration with larger defense programs.

The agencies want to see that their investment produces real outcomes. Documenting commercialization progress throughout Phase II — revenue generated, partnerships formed, follow-on investment raised — positions you for continued relationships with the agency and credibility with future funders.

Finding the Right Opportunities with Less Guesswork

Navigating SBIR solicitations, deadlines, agency-specific requirements, and Phase II eligibility windows is a real operational burden for small businesses that are simultaneously trying to do the actual work of innovation. Missing a deadline or applying to the wrong solicitation can cost months of momentum.

FundFly was built to solve exactly this problem. Using AI-powered matching, FundFly connects your business profile to relevant SBIR and STTR opportunities across more than 1 million live funding listings — including Phase II solicitations across every major federal agency. The platform surfaces the opportunities most relevant to your technology area, team profile, and development stage, so you spend less time searching and more time building a competitive application.

If you are preparing for a Phase II transition or just beginning to map out your SBIR strategy, try FundFly today and let AI do the heavy lifting on opportunity discovery.